Final hours! Save up to 55% OFF InvestingProCLAIM SALE

ETFMG Treatments, Testing and Advancements ETF (GERM)

NYSE
Currency in USD
19.16
0.00(0.00%)
Real-time Data
Day's Range
19.1619.28
52 wk Range
15.6720.20
Prev. Close
19.21
Price Open
19.28
Volume
0
Average Volume (3m)
1,280
1-Year Change
-0.1%
Day's Range
19.16-19.28
52 wk Range
15.67-20.2
Market Cap
9.58M
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
Type:ETF
Issuer:ETFMG
Asset Class:Bond
How do you feel today about GERM?
Vote to see community's results!
or
Show more

ETFMG Treatments, Testing and Advancements ETF Company Profile

As of September 10, 2024, Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF has gone out of business. Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is an exchange traded fund launched and managed by Amplify Investments LLC. It is co-managed by Tidal Investments LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating in companies that perform research, development, and commercialization of treatments or vaccines for infectious diseases or engage in the research, development, manufacturing, and provision of biological tests for patients. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the Prime Treatments, Testing and Advancements Index, by using full replication technique. Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF was formed on June 17, 2020 and is domiciled in the United States.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.